Teladoc Health Inc (NYSE:TDOC)’s traded shares stood at 10.08 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $10.99, to imply a decrease of -1.70% or -$0.19 in intraday trading. The TDOC share’s 52-week high remains $15.95, putting it -45.13% down since that peak but still an impressive 38.49% since price per share fell to its 52-week low of $6.76.
Analysts have given a consensus recommendation of Hold for Teladoc Health Inc (TDOC), translating to a mean rating of 2.45. Of 19 analyst(s) looking at the stock, 0 analyst(s) give TDOC a Sell rating. 0 of those analysts rate the stock as Overweight while 10 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.37.
Teladoc Health Inc (NYSE:TDOC) trade information
After registering a -1.70% downside in the last session, Teladoc Health Inc (TDOC) has traded red over the past five days. The 5-day price performance for the stock is -20.19%, and 7.64% over 30 days. With these gigs, the year-to-date price performance is 20.90%.
The extremes give us $9 and $13 for target low and target high price respectively. As such, TDOC has been trading -18.29% off suggested target high and 18.11% from its likely low.
Teladoc Health Inc (TDOC) estimates and forecasts
The rating firms project that company’s revenue will shrink -1.35% compared to the previous financial year.
Revenue forecast for the current quarter as set by 17 analysts is 629.31M. Meanwhile, for the current quarter, a total of 17 analyst(s) estimate revenue growth to 629.62M.Earnings reports from the last fiscal year show that sales brought in 646.13M and 642.44M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -2.60% before dropping -2.00% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 1.91% for the past 5-year period. While 2025 is set for a 84.11% return in earnings, projections for the next 5 years are at 54.31% annually.
TDOC Dividends
Teladoc Health Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 17.22 million shares, or about 10.2643% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $168.38 million.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Teladoc Health Inc (TDOC) shares. Going by data provided on Sep 30, 2024, Vanguard Total Stock Market Index Fund holds roughly 5.34 shares. This is just over 3.10% of the total shares, with a market valuation of $58.67 million. Data from the same date shows that the other fund manager holds a little less at 4.82, or 2.80% of the shares, all valued at about 53.0 million.
